- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03333525
Does Protein and Fat Content of Meal Increase Glucose Concentrations
November 2, 2017 updated by: Neşe Kaya, TC Erciyes University
Does High-Protein High-Fat Meal Increase Postprandial Glucose Concentrations and Meal-Time Insulin Requirements in Patients With Type 1 Diabetes on Basal-Bolus Insulin Regimen: A Randomized Controlled Trial
The study investigated the effects of fat protein counting (CFP) in addition to carbohydrate (CARB) counting for calculating prandial insulin dosage on blood glucose profile in patients with type 1 diabetes (T1D) on basal-bolus insulin therapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this single center, crossover, randomized, controlled study, control meal (SM: standard meal using carbohydrate counting method) and three test meals (HPM: high protein meal using carbohydrate counting method, HPFM-a: high protein-fat meal using carbohydrate counting method and HPFM-b: high protein-fat meal using carbohydrate and fat-protein counting method) were compared on postprandial early (0-120 minutes), late (120-240 minutes) and total (0-240 minutes) glucose response.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Subjects:
- had Type1 Diabetes for at least 1 years;
- use multiple dose (basal-bolus) insulin therapy;
- use fast-acting insulin analogs (lispro, glulisine, and aspart) and basal insulin analogs (detemir, glargine);
- daily inslin dose ≥0.5 IU/kg/day.
Exclusion Criteria:
Subjects:
- had any restrictive food intake disorders (eg celiac disease or food allergy);
- had any diabetes complications (eg neuropathy, nephropathy or retinopathy);
- diagnosed for <1 year;
- were using corticosteroid or any medication that could effect gastric emptying;
- did exercise or had hypoglycemia or ketoacidosis within 24 hour before the test meals;
- had overweight or obese (BMI z score: ≥ 1SD and ≥ 2SD respectively);
- had not on follicular or peri-ovulatory phases of their menstrual cycles (for females).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Insulin dose-CARB counting HPM group
HPM (high protein meal), contained 36 g protein,17 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30
h) in the hospital.
The glycaemic index (GI) of meal was 60.40.
The insulin dose for meal was calculated according to the carbohydrate counting (insulin-to-carbohydrate ratio-ICR).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
|
Calculation of insulin dosages For CARB counting meals using insulin-carbohydrate ratio for dosing mealtime boluses.
For fat protein counting meal ICR and additionally fat-protein unit were used for dosing of mealtime boluses.
|
Experimental: Insulin dose-CARB counting HPFM group
HPFM (high protein-high fat meal), contained 36 g protein,30 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30
h) in the hospital The glycaemic index (GI) of meal was 60.40.
The insulin dose for meal was calculated according to the carbohydrate counting (insulin-to-carbohydrate ratio-ICR).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
|
Calculation of insulin dosages For CARB counting meals using insulin-carbohydrate ratio for dosing mealtime boluses.
For fat protein counting meal ICR and additionally fat-protein unit were used for dosing of mealtime boluses.
|
Experimental: Insulin dose-CARB+FPU counting-HPFM
HPFM (high protein-high fat meal), contained 36 g protein,30 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30
h) in the hospital.
The glycaemic index (GI) of meal was 60.40.
The insulin dose for meal was calculated according to the carbohydrate counting plus fat-protein counting (insulin-to-carbohydrate ratio-ICR and fat-protein unit-FPU).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
|
Calculation of insulin dosages For CARB counting meals using insulin-carbohydrate ratio for dosing mealtime boluses.
For fat protein counting meal ICR and additionally fat-protein unit were used for dosing of mealtime boluses.
|
Active Comparator: Insulin dose-CARB counting SM group
SM (standart meal), contained 24 g protein,17 g fat, 70 g carbohydrate and 11.5 g fiber, was given to the subjects in breakfast meal (08.30
h) in the hospital.
The glycaemic index (GI) of meal was 60.40.
The insulin dose for meal was calculated according to the carbohydrate counting (insulin-to-carbohydrate ratio-ICR and fat-protein unit-FPU).Capillary blood glucose values were collected and recorded before (0 min) and every 30 minutes thereafter for 240 minutes.
|
Calculation of insulin dosages For CARB counting meals using insulin-carbohydrate ratio for dosing mealtime boluses.
For fat protein counting meal ICR and additionally fat-protein unit were used for dosing of mealtime boluses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change Postprandial Glucose Concentrations
Time Frame: 0-240 minutes
|
Change from baseline capillary blood glucose values at 240 min after control and test meals consumption.
|
0-240 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial insulin need
Time Frame: [Time Frame: 0-240 minutes]
|
Insulin dosage was calculated by FPU (is defined as 100 calories of fat and protein) for HFPM-b meal.
|
[Time Frame: 0-240 minutes]
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 10, 2013
Primary Completion (Actual)
February 20, 2014
Study Completion (Actual)
February 20, 2014
Study Registration Dates
First Submitted
October 26, 2017
First Submitted That Met QC Criteria
November 2, 2017
First Posted (Actual)
November 7, 2017
Study Record Updates
Last Update Posted (Actual)
November 7, 2017
Last Update Submitted That Met QC Criteria
November 2, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013/173
- KEPAN (Other Grant/Funding Number: Turkish Clinical Enteral Parenteral Nutrition Society)
- ESPEN Travel Grant (36 th) (Other Identifier: The European Society for Clinical Nutrition and Metabolism)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Spiden AGDCB Research AGRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
Hoffmann-La RocheRoche DiagnosticsCompletedDiabetes Mellitus Type 2, Diabetes Mellitus Type 1Germany
Clinical Trials on Calculation of insulin dosages for different meals
-
Istituti Clinici Scientifici Maugeri SpAUniversita di VeronaRecruitingCOPD | Failure PulmonaryItaly
-
Kocaeli Derince Education and Research HospitalCompleted
-
Charite University, Berlin, GermanyAbbottCompleted
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyRecruitingPostoperative Delirium (POD)Switzerland
-
University of MichiganCompletedDental Pulp DiseasesUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityRecruiting
-
CHU de ReimsCompleted
-
Centre d'Etudes et de Recherche pour l'Intensification...RecruitingDiabetes Mellitus, Type 1 | Closed Loop | Adolescents (12 to 17 Years Old)Belgium, France, Germany
-
Emory UniversityNovo Nordisk A/SCompletedType 2 DiabetesUnited States